News for hackers. Stuff that matters.
Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by handmodel on Saturday July 10, 2021 @04:14PM (#27796118)
A huge oversight was when it was approved for phrase III they should have run many (a dozen?) different trials at different dose amounts. It was already proven to be safe and nailing the dosing would have helped get shots into arms faster in the US and elsewhere.

I'm on the extreme end of thinking it should have been approved faster - but even if you are a bit of a traditionalist I don't see how running concurrent trials on such an important potential vaccine wouldn't be a huge win.

Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by tgsovlerkhgsel on Saturday July 10, 2021 @04:31PM (#27796218)
Or at least started running a second run of modified trials as soon as the phase 3 trials passed.

The trials take something like 3 months from first shot to results, I think. It took a lot more than 3 months from phase 3 completed to most people vaccinated in most Western countries and obviously much longer in developing ones.

But there is very little financial incentive to run such trials once you have a vaccine approved...

Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by handmodel on Saturday July 10, 2021 @04:53PM (#27796388)
100%

The problem is on the government side. They should have paid for this. It would have saved them money too - if it turned out they only needed to give out one shot of the mRNA doses or that they could cut down on dosage.

Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by mahogany on Saturday July 10, 2021 @04:50PM (#27796364)
Finding the optimal dose is done in phase II, where various dose levels are tested on different groups of people. Phase III happens after the dose level is confirmed, and then you roll that out to tens of thousands of people. I think the main point of phase III is to test the final candidate, so you're not really experimenting with the formula at that point.

If you check the papers for the mRNA vaccines, you can see that they did run several different dose levels and got pretty clear feedback that some were too high or too low, before moving on to phase III.

Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by handmodel on Saturday July 10, 2021 @04:56PM (#27796413)
I don't think this is accurate.

If you read the abstract in phase II they gave it to a small amount of people and looked in detail how the immune system responded in these individuals. This is very granular data.

Phase III is more like "We have no idea what the immune system did in certain people - but only 0.1% of vaccinated people ended up in hospital compared to 2% of placebo" or whatever.

The important thing for the vaccine was too limit death and hospitalization. And phase II didn't tell us clear info on that.

What if they had found that half the dosage ended up in the same number of hospitalizations? There's no way to get that from phase II data.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871769/

Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by mahogany on Saturday July 10, 2021 @05:16PM (#27796528)
Are you saying that my use of "clear feedback" isn't accurate? I mean this with respect to what was in scope for phase II, although I could see an argument against using that subjective language. Also, even more dosages were tested in phase I, again on a few number of people, but I'm not sure if that's different from how it's usually done.

> The important thing for the vaccine was too limit death and hospitalization. And phase II didn't tell us clear info on that.

Phase II is primarily to test that the "candidate is safe, sufficiently immunogenic, and maybe protective"[1]. It's not clear to me that testing hospitalization percentage is in scope.

[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944327/

Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by handmodel on Saturday July 10, 2021 @06:22PM (#27796902)
You said in your previous comment that phase II was about finding the "optimal dose" but that testing hospitalization data is not within the scope of phase II.

In a very real-world sense the "optimal dose" is 100% about finding hospitalization/health data. The "optimal dose" in phase II is about the microbiology and isn't very precise in terms of how it translates to real world effects.

Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by mahogany on Saturday July 10, 2021 @09:15PM (#27797739)
Sure, the phrase "optimal dose" can be dependent on context. Maybe the optimal dose with respect to a decrease in hospitalization turns out to be 79.19 ug, and of course that's not going to be found when you only try 25, 50, 100, and 250.

But while a decrease in hospitalization is important, I disagree that it's the only thing that we should be optimizing against. I'm not sure what you mean by health data, but safety and immunogenicity (which might be upstream of hospitalization) are incredibly important to consider in the choice of dosage as well, and that's what optimal dose in the context of trials means. This is the context which I meant it in, and I'm just borrowing this terminology from other places, e.g.:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944327/ https://pubmed.ncbi.nlm.nih.gov/29420118/

Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by handmodel on Saturday July 10, 2021 @09:52PM (#27797889)
After reading your links I think it is more clear that "optimal dose" does not mean optimal dose for the patient or total population. It is optimal dose such that a single phase III trial would detect a measurable effect.

Once its approved already at a set dose, the "ideal dose" for future use is probably not the same as the "optimal dose" that maximized probability of approval.

"We propose a Bayesian utility approach (BUART) to randomized Phase II clinical trials which uses a first-order bivariate normal dynamic linear model for efficacy and safety in order to determine the optimal dose and study population in a subsequent Phase III clinical trial. "

Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by ebiester on Saturday July 10, 2021 @04:35PM (#27796233)
Tens of thousands were in this trial. How many hundreds of thousands of people should be sufficient to get it out the door?
Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by handmodel on Saturday July 10, 2021 @04:52PM (#27796379)
It would still only be the same number of people per trial. They wouldn't have gotten trouble finding volunteers.

And even if they just prioritized starting the first one ASAP - they didn't do any dosage testing until after it had been released to general public for months. Even if not ideal they could have started dosage trials in November after all the data from the original was done. Instead, they waited six months before even considering this.

Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by belltaco on Saturday July 10, 2021 @05:07PM (#27796486)
Even if you find all those multiple number of volunteers, you still need additional vaccine doses to be manufactured, which can take longer because they need more supplies from third parties, and scale up early. Not to mention all the extra staff to run the trials.

If somehow they're able to run trials on 12x the volunteers, I would rather that they increase the participants by 12x for the final dose so that you get more confidence in the Phase 3 study results and in finding rare side effects.

Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by Spooky23 on Saturday July 10, 2021 @05:06PM (#27796475)
You have to be cautious as we live in an era where anti vaccine beliefs are commonplace.
Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by belltaco on Saturday July 10, 2021 @04:45PM (#27796323)
It would be hard to recruit that many volunteers and staff to run a dozen trials, and reducing the study group size would mean less confidence in the results. Already we have seen blood clots and heart inflammation show up at rates that won't be caught even in larger scale trials.
Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by Spooky23 on Saturday July 10, 2021 @04:36PM (#27796246)
Once manufacturing ramped I don’t think vaccine quantities are an issue.

Transport, preparation and process are very operationally challenging.

Re:Quarter-dose of Moderna Covid vaccine still rouses a big ... by loceng on Saturday July 10, 2021 @04:35PM (#27796238)
I'm curious what your knowledge or thoughts on potential non-vaccine treatments are like Ivernectin - and what you think of the response to them?

Edit: ridiculous that HN community downvotes attempts to have conversation; you're part of the problem.